Peter Jüni to Humans
This is a "connection" page, showing publications Peter Jüni has written about Humans.
Connection Strength
0.193
-
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10; 22(1):202.
Score: 0.007
-
Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study. CMAJ. 2020 05 25; 192(21):E566-E573.
Score: 0.007
-
Dyspnoea in the GLOBAL LEADERS trial - Authors' reply. Lancet. 2019 06 15; 393(10189):2393-2394.
Score: 0.007
-
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial. Eur Heart J. 2019 04 14; 40(15):1226-1232.
Score: 0.007
-
Predicting transition from acute to chronic low back pain with quantitative sensory tests-A prospective cohort study in the primary care setting. Eur J Pain. 2019 05; 23(5):894-907.
Score: 0.006
-
Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ. 2017 Nov 07; 359:j4784.
Score: 0.006
-
Caesarean sections and private insurance: systematic review and meta-analysis. BMJ Open. 2017 Aug 21; 7(8):e016600.
Score: 0.006
-
Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients. Curr Opin Cardiol. 2017 Mar; 32(2):117-122.
Score: 0.006
-
Caesarean sections and for-profit status of hospitals: systematic review and meta-analysis. BMJ Open. 2017 02 17; 7(2):e013670.
Score: 0.006
-
Intra-articular Corticosteroids for Osteoarthritis of the Knee. JAMA. 2016 12 27; 316(24):2671-2672.
Score: 0.006
-
Discriminative ability of reflex receptive fields to distinguish patients with acute and chronic low back pain. Pain. 2016 12; 157(12):2664-2671.
Score: 0.006
-
BEST-When a Study Falls Short of Its Acronym. Am J Cardiol. 2015 Sep 15; 116(6):995.
Score: 0.005
-
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial. JAMA Netw Open. 2021 08 02; 4(8):e2121867.
Score: 0.002
-
A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada. Ann Epidemiol. 2021 11; 63:63-67.
Score: 0.002
-
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. JAMA. 2021 07 20; 326(3):257-265.
Score: 0.002
-
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada. CMAJ. 2021 04 26; 193(17):E592-E600.
Score: 0.002
-
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial. Trials. 2021 Mar 22; 22(1):224.
Score: 0.002
-
Public Health Interventions, Epidemic Growth, and Regional Variation of the 1918 Influenza Pandemic Outbreak in a Swiss Canton and Its Greater Regions. Ann Intern Med. 2021 04; 174(4):533-539.
Score: 0.002
-
Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations. Sci Total Environ. 2021 May 20; 770:145319.
Score: 0.002
-
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 10 06; 324(13):1330-1341.
Score: 0.002
-
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 11; 18(11):2958-2967.
Score: 0.002
-
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Trials. 2020 Aug 24; 21(1):734.
Score: 0.002
-
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial. Trials. 2020 Aug 16; 21(1):717.
Score: 0.002
-
Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia. Diabetologia. 2020 11; 63(11):2488-2490.
Score: 0.002
-
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. Trials. 2020 Jul 14; 21(1):647.
Score: 0.002
-
COVID-19 randomised trial protocols: rapid publication without barriers. Trials. 2020 04 15; 21(1):327.
Score: 0.002
-
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019 10 07; 40(38):3143-3153.
Score: 0.002
-
Can quantitative sensory tests predict failed back surgery?: A prospective cohort study. Eur J Anaesthesiol. 2019 09; 36(9):695-704.
Score: 0.002
-
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial. Circulation. 2019 11 19; 140(21):1693-1702.
Score: 0.002
-
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. Eur Heart J. 2019 08 14; 40(31):2595-2604.
Score: 0.002
-
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial. EuroIntervention. 2019 Aug 09; 15(6):e539-e546.
Score: 0.002
-
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial. Circ Cardiovasc Interv. 2019 08; 12(8):e008024.
Score: 0.002
-
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). Eur Heart J. 2019 07 01; 40(25):2070-2085.
Score: 0.002
-
Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur Heart J. 2019 04 01; 40(13):1081-1088.
Score: 0.002
-
2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019 Feb 20; 14(14):1435-1534.
Score: 0.002
-
Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019 01 07; 40(2):204-212.
Score: 0.002
-
2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 01 07; 40(2):87-165.
Score: 0.002
-
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J. 2019 01 07; 40(2):180-186.
Score: 0.002
-
2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019 01 01; 55(1):4-90.
Score: 0.002
-
Increased subchondral bone thickness in hips with cam-type femoroacetabular impingement. Hip Int. 2019 Jul; 29(4):430-437.
Score: 0.002
-
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA. 2018 12 04; 320(21):2251-2259.
Score: 0.002
-
Pump, pipes, and filter: do SGLT2 inhibitors cover it all? Lancet. 2019 01 05; 393(10166):3-5.
Score: 0.002
-
Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Circulation. 2018 10 23; 138(17):1797-1804.
Score: 0.002
-
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet. 2018 09 01; 392(10149):737-746.
Score: 0.002
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018 09 15; 392(10151):940-949.
Score: 0.002
-
Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery. N Engl J Med. 2018 09 27; 379(13):1224-1233.
Score: 0.002
-
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. EuroIntervention. 2018 Aug 20; 14(6):692-699.
Score: 0.002
-
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology. EuroIntervention. 2018 Aug 20; 14(6):708-715.
Score: 0.002
-
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Swiss Med Wkly. 2018; 148:w14640.
Score: 0.002
-
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. Int J Cardiol. 2018 Nov 01; 270:7-13.
Score: 0.002
-
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018 07 19; 379(3):250-259.
Score: 0.002
-
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. Eur Heart J. 2018 05 07; 39(18):1591-1601.
Score: 0.002
-
Homograft Versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis. Innovations (Phila). 2018 May/Jun; 13(3):163-170.
Score: 0.002
-
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Apr; 55(4):457-464.
Score: 0.002
-
Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials. BMJ. 2018 02 21; 360:k504.
Score: 0.002
-
Non-Technical Skills for Surgeons (NOTSS): Critical appraisal of its measurement properties. Am J Surg. 2018 11; 216(5):990-997.
Score: 0.002
-
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention. 2018 01 20; 13(13):1565-1573.
Score: 0.002
-
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. EuroIntervention. 2018 01 20; 13(13):1574-1586.
Score: 0.002
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018 01 01; 53(1):34-78.
Score: 0.001
-
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J. 2017 Dec 14; 38(47):3493-3502.
Score: 0.001
-
Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients. PLoS One. 2017; 12(12):e0189309.
Score: 0.001
-
Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy. Circulation. 2018 04 03; 137(14):1475-1485.
Score: 0.001
-
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery. N Engl J Med. 2017 11 30; 377(22):2133-2144.
Score: 0.001
-
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). Circulation. 2018 01 30; 137(5):480-487.
Score: 0.001
-
Measurement Error of a Simplified Protocol for Quantitative Sensory Tests in Chronic Pain Patients. Reg Anesth Pain Med. 2017 Sep/Oct; 42(5):660-668.
Score: 0.001
-
Systematic review and meta-analysis of chordal replacement versus leaflet resection for posterior mitral leaflet prolapse. J Thorac Cardiovasc Surg. 2018 01; 155(1):120-128.e10.
Score: 0.001
-
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study. PLoS One. 2017; 12(8):e0182632.
Score: 0.001
-
Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain. Scand J Pain. 2017 10; 17:107-115.
Score: 0.001
-
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction. EuroIntervention. 2017 08 04; 13(5):e613-e616.
Score: 0.001
-
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017 Aug 01; 52(2):206-217.
Score: 0.001
-
Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation. Circ Cardiovasc Interv. 2017 Aug; 10(8).
Score: 0.001
-
Rates and predictors of hospital readmission after transcatheter aortic valve implantation. Eur Heart J. 2017 Jul 21; 38(28):2211-2217.
Score: 0.001
-
Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial. BMJ Open. 2017 06 12; 7(5):e015686.
Score: 0.001
-
Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial). BMJ Open. 2017 05 30; 7(5):e015032.
Score: 0.001
-
Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts. Int J Cardiol. 2017 Sep 15; 243:150-155.
Score: 0.001
-
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort. Eur Heart J Acute Cardiovasc Care. 2018 Sep; 7(6):522-531.
Score: 0.001
-
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017 Apr 07; 12(18):e2170-e2176.
Score: 0.001
-
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J. 2017 04 07; 38(14):1069-1080.
Score: 0.001
-
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial. J Am Coll Cardiol. 2017 May 23; 69(20):2530-2537.
Score: 0.001
-
Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study. Syst Rev. 2017 03 03; 6(1):44.
Score: 0.001
-
Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data. BMJ Open. 2017 02 17; 7(2):e013770.
Score: 0.001
-
Impact of total arterial revascularization on long term survival: A systematic review and meta-analysis of 130,305 patients. Int J Cardiol. 2017 Apr 15; 233:29-36.
Score: 0.001
-
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] Kardiol Pol. 2017; 75(12):1217-1299.
Score: 0.001
-
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care. 2018 Mar; 7(2):129-138.
Score: 0.001
-
Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study. BMJ Open. 2016 12 21; 6(12):e012938.
Score: 0.001
-
A systematic review and meta-analysis of in situ versus composite bilateral internal thoracic artery grafting. J Thorac Cardiovasc Surg. 2017 05; 153(5):1108-1116.e16.
Score: 0.001
-
Factors affecting screening for hepatocellular carcinoma. Ann Hepatol. 2014 Mar-Apr; 13(2):204-10.
Score: 0.001
-
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention. 2014 Jan 22; 9(9):1076-84.
Score: 0.001